ID   U-2904
AC   CVCL_X504
SY   U 2904; U2904
DR   Cell_Model_Passport; SIDM01417
DR   DepMap; ACH-001677
DR   DSMZ; ACC-768
DR   DSMZCellDive; ACC-768
DR   Wikidata; Q54973559
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7591289;
RX   PubMed=17926183;
RX   PubMed=26727417;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 24 hours (PubMed=7591289); ~25-35 hours (DSMZ=ACC-768).
CC   Omics: Deep exome analysis.
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, centroblastic-type.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001677; DSMZ=ACC-768
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 14,17.3 (DepMap=ACH-001677)
ST   D18S51: 14,18 (DSMZ=ACC-768)
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,19
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 11,16
ST   FGA: 19,24
ST   Penta D: 9,10
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 16
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=7591289; DOI=10.1002/ijc.2910630517;
RA   Sambade C., Sallstrom J., Wiklund H.J., Enblad G., Kivi S.,
RA   Gartner M.F.R.M., Zech L., Glimelius B., Sundstrom C.;
RT   "A novel human B-cell line (U-2904) bearing t(8;14) and t(14;18)
RT   translocations.";
RL   Int. J. Cancer 63:710-715(1995).
//
RX   PubMed=17926183; DOI=10.1080/10428190701636443;
RA   Fridberg M., Servin A., Anagnostaki L., Linderoth J., Berglund M.,
RA   Soderberg O., Enblad G., Rosen A., Mustelin T., Jerkeman M.,
RA   Persson J.L., Wingren A.G.;
RT   "Protein expression and cellular localization in two prognostic
RT   subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70
RT   and PKC-beta II in the non-germinal center group and poor survival in
RT   patients deficient in nuclear PTEN.";
RL   Leuk. Lymphoma 48:2221-2232(2007).
//
RX   PubMed=26727417; DOI=10.3109/10428194.2015.1108414;
RA   Drexler H.G., Eberth S., Nagel S., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for double-hit
RT   B-cell lymphomas.";
RL   Leuk. Lymphoma 57:1015-1020(2016).
//